Post-Traumatic Stress Disorder (PTSD)

Many people suffer from PTSD and our previous PTSD trial has been updated to reflect that. Our previous trial was only open to military personnel and veterans. The trial has been re-developed to include civilians as well. Please contact Sidney Sechio, clinical research coordinator, at 860-506-0320.

Symptoms May Include:

• Agitation
• Irritability

• Hypervigilance
• Social Isolation

• Flashback
• Severe Anxiety

• Loss of Interest in Activities
• Insomnia or Nightmares

• Emotional Detachment
• Unwanted Thoughts

You May Qualify for the PTSD Study If…

• If you are 18 to 65 years of age.
• Have experienced or witnessed a traumatic event where you felt your life was in danger, saw someone die, suffered serious bodily injury or sexual violence, or experienced the sudden unexpected death of someone close to you within the past 9 years.
• Have unwanted memories, flashbacks, are struggling with fear, anxiety and isolation from loved ones, and avoid situations that remind you of the trauma.

The PTSD study is evaluating an investigational medication, in combination with Sertraline, for the treatment of PTSD. Both Sertraline and the investigational medication in this study are approved for use in the United States. Sertraline is approved to treat depression and PTSD and the investigational medication is approved in combination with antidepressants for the treatment of major depressive disorder (MDD) and schizophrenia. Doctors believe the combination of the two medications could be a possible treatment option for PTSD in the future.

All study-related visits, tests, and drugs may be provided at no cost. In addition, reimbursement for study-related travel may be provided.
The study will include approximately 11 visits over approximately 17 weeks.